Our R&D portfolio for cutaneous leishmaniasis
What we have achieved
Through collaborations with the pharmaceutical industry, biotechnology companies, academia, and other product development partnerships, we have identified several promising compounds that are now in different stages of development. In addition, our support for regional disease research platforms is helping to build and consolidate research capacity in endemic countries.
What we are doing for people living with cutaneous leishmaniasis
Our goal is to deliver short, safe, non-invasive, efficacious, affordable, and field-friendly treatments for all forms of cutaneous leishmaniasis, including topical, oral, and immunomodulator therapies.
Get our latest news, personal stories, research articles, and job opportunities.